The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Futran, J.
Right arrow Articles by Ashman, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Futran, J.
Right arrow Articles by Ashman, R. F.

The Journal of Immunology, Vol 143, Issue 3 787-792, Copyright © 1989 by American Association of Immunologists

ARTICLES

Transferrin receptor synthesis is an early event in B cell activation

J Futran, JD Kemp, EH Field, A Vora and RF Ashman
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.

Purified, small resting mouse B cells appear to express low levels of transferrin receptor (TfR) as detected by flow cytometry. Moreover, when such cells are stimulated with LPS or F(ab')2 anti-mu, they show increased expression of TfR as early as 4 h after activation when the cells are at the boundary of G0 and G1 phase by cell cycle analysis. Cells treated with anti-mu increased TfR expression gradually, reaching a plateau after 46 h, whereas cells with LPS reached their plateau by 12 h. The kinetics of induction of increased TfR expression was similar for both small and large B cells. Inhibition of protein synthesis with anisomycin or inhibition of transcription with actinomycin-D blocked the increased expression of TfR at 4 h. Northern blot analysis showed a marked increase of TfR mRNA at 2 and 4 h with either anti-mu or LPS which was then followed by an apparent decline at 16 h. These findings together with other recent studies justify reevaluation of the generally accepted models placing TfR induction late in the G1 phase of the lymphocyte activation sequence. They support the concept that in the B lymphocyte the TfR gene is selectively transcribed earlier than previously thought, before the general increase in RNA synthesis.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. Wang, L. Albritton, and S. R. Ross
Identification of the Segments of the Mouse Transferrin Receptor 1 Required for Mouse Mammary Tumor Virus Infection
J. Biol. Chem., April 14, 2006; 281(15): 10243 - 10249.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Burzyn, J. C. Rassa, D. Kim, I. Nepomnaschy, S. R. Ross, and I. Piazzon
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a Retrovirus
J. Virol., January 15, 2004; 78(2): 576 - 584.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. M. Ned, W. Swat, and N. C. Andrews
Transferrin receptor 1 is differentially required in lymphocyte development
Blood, November 15, 2003; 102(10): 3711 - 3718.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Ehrlich, K. L. Buchanan, F. Tsien, G. Jiang, B. Sun, W. Uicker, C. M.R. Weemaes, D. Smeets, K. Sperling, B. H. Belohradsky, et al.
DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes
Hum. Mol. Genet., December 1, 2001; 10(25): 2917 - 2931.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. R. Chitambar and J. P. Wereley
Iron transport in a lymphoid cell line with the hemochromatosis C282Y mutation
Blood, May 1, 2001; 97(9): 2734 - 2740.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.